Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$554M |
| 2 |
Apple
AAPL
|
+$513M |
| 3 |
Illumina
ILMN
|
+$360M |
| 4 |
argenx
ARGX
|
+$304M |
| 5 |
CTLT
CATALENT, INC.
CTLT
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$482M |
| 2 |
Sherwin-Williams
SHW
|
+$314M |
| 3 |
AbbVie
ABBV
|
+$310M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$244M |
| 5 |
Atlassian
TEAM
|
+$233M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.47% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2426
Accel Entertainment
ACEL
$995M
| $227K | ﹤0.01% |
24,935
+13,565
| +119% | +$122K |
|
2427
Artivion
AORT
$1.38B
| $226K | ﹤0.01% |
+17,285
| New | +$221K |
|
2428
Brookdale Senior Living
BKD
$3B
| $226K | ﹤0.01% |
76,588
+39,350
| +106% | +$113K |
|
|
DHIL
2429
DELISTED
Diamond Hill
DHIL
| $224K | ﹤0.01% |
+1,367
| New | +$243K |
|
|
CVGW
2430
DELISTED
Calavo Growers
CVGW
| $224K | ﹤0.01% |
+7,788
| New | +$234K |
|
2431
Life Time Group Holdings
LTH
$9.79B
| $224K | ﹤0.01% |
+14,013
| New | +$240K |
|
2432
Stoneridge
SRI
$193M
| $223K | ﹤0.01% |
+11,948
| New | +$257K |
|
2433
Grab Holdings Warrant
GRABW
$790K
| $222K | ﹤0.01% |
403,754
-182
| -0% | -$115 |
|
2434
Arlo Technologies
ARLO
$1.59B
| $222K | ﹤0.01% |
36,727
+20,223
| +123% | +$89.6K |
|
2435
Acco Brands
ACCO
$396M
| $222K | ﹤0.01% |
41,722
+22,530
| +117% | +$129K |
|
2436
Byline Bancorp
BY
$1.76B
| $222K | ﹤0.01% |
+10,263
| New | +$239K |
|
2437
Editas Medicine
EDIT
$453M
| $222K | ﹤0.01% |
30,548
+16,857
| +123% | +$150K |
|
2438
Central Pacific Financial
CPF
$996M
| $222K | ﹤0.01% |
+12,373
| New | +$263K |
|
2439
SmartFinancial
SMBK
$888M
| $221K | ﹤0.01% |
+9,545
| New | +$249K |
|
2440
Genesco
GCO
$409M
| $220K | ﹤0.01% |
+5,982
| New | +$262K |
|
|
VERV
2441
DELISTED
Verve Therapeutics
VERV
| $220K | ﹤0.01% |
+15,286
| New | +$299K |
|
2442
E.W. Scripps
SSP
$307M
| $220K | ﹤0.01% |
23,396
+12,738
| +120% | +$160K |
|
2443
Vaalco Energy
EGY
$620M
| $220K | ﹤0.01% |
48,539
+4,340
| +10% | +$19.8K |
|
|
CLDT
2444
Chatham Lodging
CLDT
$580M
| $218K | ﹤0.01% |
+20,799
| New | +$254K |
|
|
FPI
2445
Farmland Partners
FPI
$425M
| $218K | ﹤0.01% |
+20,329
| New | +$238K |
|
2446
Universal Insurance Holdings
UVE
$1.19B
| $218K | ﹤0.01% |
+11,948
| New | +$177K |
|
|
EWCZ
2447
DELISTED
European Wax Center
EWCZ
| $217K | ﹤0.01% |
+11,403
| New | +$200K |
|
2448
CareDx
CDNA
$2.44B
| $217K | ﹤0.01% |
23,680
+13,149
| +125% | +$168K |
|
2449
Vanguard Morningstar Growth ETF
VUG
$228B
| $216K | ﹤0.01% |
5,196
-3,714
| -42% | -$144K |
|
2450
Franklin Covey
FC
$235M
| $216K | ﹤0.01% |
+5,610
| New | +$259K |
|
Similar funds
Janus Henderson Group's Q1 2023 Portfolio in Review
As of Q1 2023, Janus Henderson Group held 2,845 positions worth $152B, up 8.3% from $140B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Janus Henderson Group's Q1 2023 filing shows 389 new, 1,670 increased, 578 reduced and 160 closed positions. Its largest new stake was GE HealthCare: 882,749 shares worth $72.4M. The largest sale was Meta Platforms (Facebook), an estimated $482M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Janus Henderson Group's largest Q1 2023 buy was GE HealthCare: 882,749 shares worth $72.4M.
- Janus Henderson Group added most to Linde in Q1 2023, an estimated $554M increase.
- Janus Henderson Group's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $482M.
- Janus Henderson Group fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $31.7M.
- Janus Henderson Group's ten largest holdings make up 24% of its $152B portfolio in Q1 2023.
- Janus Henderson Group opened 389 new positions and closed 160 in Q1 2023.
- Janus Henderson Group's portfolio value rose 8.3% quarter-over-quarter to $152B.
Based on Janus Henderson Group's 13F filing for Q1 2023, filed 15 May 2023.